Minimed Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Minimed Group (MMED).

Price Target Range — 4 Quarters

Analyst Consensus — 13 Analysts

11Buy

2Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$25Upside to Avg. PT+42.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	Jefferies	Michael Toomey	Initiate	Hold	$22
Oct 8, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$26→$28
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Equal-Weight	$22
Sep 24, 2026	Truist Securities	Richard Newitter	Initiate	Buy	$29
Sep 3, 2026	Morgan Stanley	Kallum Titchmarsh	PT Raise	Overweight	$19→$21
Sep 2, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$23→$26
Sep 2, 2026	Evercore ISI Group	Daniel Markowitz	PT Raise	Outperform	$20→$27
Sep 2, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$22→$26
Sep 2, 2026	UBS	Patrick Wood	PT Raise	Buy	$25→$28
Sep 2, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$21→$26
Sep 2, 2026	B of A Securities	Travis Steed	PT Raise	Buy	$24→$28
Sep 1, 2026	BTIG	Marie Thibault	PT Raise	Buy	$25→$28
Jul 28, 2026	UBS	—	Assumes	Buy	$25
Jun 4, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$26→$22
May 18, 2026	B of A Securities	Travis Steed	PT Cut	Buy	$27→$20
May 12, 2026	Benchmark	Bruce Jackson	Initiate	Buy	$20
Apr 1, 2026	Barclays	Matt Miksic	Initiate	Overweight	$26
Mar 31, 2026	William Blair	Steven Lichtman	Initiate	Outperform	—
Mar 31, 2026	Citigroup	Joanne Wuensch	Initiate	Buy	$23
Mar 31, 2026	Piper Sandler	Matt O'Brien	Initiate	Neutral	$16

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

Jefferies analyst Michael Toomey initiates coverage on Minimed Group (NASDAQ:MMED) with a Hold rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $26 to $28.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $19 to $21.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.

Benzinga Newsdesk

Minimed Group Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Minimed Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

PRO
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

PRO
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

People Also Watch

People Also Watch

Minimed Group Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Minimed Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

PROMizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

PROBarclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

PROTruist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

PROMorgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

PROCitigroup Maintains Buy on Minimed Group, Raises Price Target to $26

People Also Watch

People Also Watch

PRO
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

PRO
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

PRO
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26